Long-term mortality in adult orthotopic heart transplant recipients

Sung-Ho Jung1, Jae Joong Kim, Suk Jung Choo

  • 1Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea.

Insights

Heart transplantation offers excellent surgical results for end-stage heart failure. Long-term survival is primarily impacted by infection, malignancy, and rejection, not cardiac allograft vasculopathy.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Immunology

Background:

  • Heart transplantation is the primary treatment for end-stage heart failure.
  • Improving long-term outcomes is crucial for patient survival.

Purpose of the Study:

  • To analyze causes of death after heart transplantation.
  • To identify factors influencing long-term survival post-transplant.

Main Methods:

  • Retrospective analysis of 201 adult heart transplant recipients (1992-2008).
  • Evaluation of mortality causes and survival rates at 1, 5, and 10 years.
  • Utilized bicaval anastomosis technique since 1999.

Main Results:

  • In-hospital mortality was 1% due to sepsis.
  • Late mortality occurred in 19.4% of patients, predominantly from sepsis.
  • 1-, 5-, and 10-year survival rates were 95.5%, 86.9%, and 73.5%, respectively.
  • Cardiac deaths were rare.

Conclusions:

  • Adult heart transplantation yields excellent surgical results.
  • Long-term mortality is mainly attributed to infection, malignancy, and rejection.
  • Infection remains a significant cause of late death post-heart transplant.